Thomas Gardner: Clinical Trials

3 trials sponsored by Thomas Gardner, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Terminated 1

Follow Thomas Gardner: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction
Slit Stent II, BIKA for DCR - Epiphora, Dacryocystorhinostomy
Not applicableTerminatedThomas Gardner52020-10-162026-02-25
Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy
doxycycline monohydrate, Placebo - Diabetic Retinopathy
Phase 2CompletedThomas Gardner332009-07-012018-11-30
Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
doxycycline monohydrate, placebo - Diabetic Retinopathy
Phase 2CompletedThomas Gardner302008-07-012018-11-02

Conditions studied

Diabetes Mellitus (2)  ·  Diabetic Retinopathy (2)  ·  Lacrimal Apparatus Diseases (1)  ·  Neovascularization, Pathologic (1)

Interventions

Doxycycline (2)  ·  Dacryocystorhinostomy (1)  ·  Stents (1)

Countries

United States (3)

Top investigators

Thomas W Gardner, MD MS (1)  ·  Thomas W Gardner, MD.,MS. (1)

Results publications

PMID 24604308, PMID 24969516